Clinical trials
Expanded access Lymphoma, Large-Cell, Anaplastic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
No trials to chart.
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 2 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Daiichi Sankyo | 1 |
| Novartis Pharmaceuticals | 1 |
| Seagen Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Large-Cell, Anaplastic | 3 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Granuloma, Plasma Cell | 1 |
| Hematologic Diseases | 1 |
| Hodgkin Disease | 1 |
| Lymphoma | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Lymphoma, T-Cell, Cutaneous | 1 |
| Lymphoma, T-Cell, Peripheral | 1 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 |
Trials
Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.